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Abstract: Gene expression studies have shown that expression patterns of several genes 
have changed during the development of alcoholism. Gene expression is regulated not only 
at  the  level  of  transcription  but  also  through  alternative  splicing  of  pre-mRNA.  In  this 
review, we discuss some of the evidence suggesting that alternative splicing of candidate 
genes  such  as  DRD2  (encoding  dopamine  D2  receptor)  may  form  the  basis  of  the 
mechanisms  underlying  the  pathophysiology  of  alcoholism.  These  reports  suggest  that 
aberrant expression of splice variants affects alcohol sensitivities, and alcohol consumption 
also regulates alternative splicing. Thus, investigations of alternative splicing are essential 
for understanding the molecular events underlying the development of alcoholism. 
Keywords:  alcoholism;  alternative  splicing;  dopamine;  NMDA;  GABA;  voltage-gated 
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1. Introduction 
Alternative pre-mRNA splicing makes a large contribution to proteomic diversity. In alternative 
splicing,  various  potential  splice  sites  of  the  pre-mRNA  from  a  single  gene  are  used  in  various 
combinations that lead to the translation of several functionally distinct protein isoforms from several 
different mRNA species. In the brain, the regulation of splice variants modulates protein functions, 
which  can  ultimately  affect  behavior  such  as  alcohol  dependence.  Alcohol  dependence  (AD)  is  a 
common, chronic and relapsing disorder with an estimated heritability of 40−60% [1]. Family and twin 
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studies have shown that genetic factors contribute to the risk of AD and genetic mapping studies have 
identified  numerous  genes  associated  with  this  risk  [2-5].  Most  of  these  genes  affect  ethanol 
metabolism, ethanol preference, or diverse brain systems, such as the reward system [6,7]. 
Alterations in expression have been shown to be involved in producing neuroadaptative changes 
following chronic ethanol consumption [8,9]. A key question in AD is the transition from controlled to 
compulsive drinking, and development of dependence may be related not only to gene expression 
modulated through transcriptional regulation but also through alternative splicing of genes, which may 
produce functionally distinct isoforms. 
In  this  review,  we  describe  several  examples  of  alternative  splicing  which  may  affect  ethanol 
preference  and  consumption.  We  propose  that  alternative  spliced  forms  may  be  important  to  the 
development of alcoholism. 
2. Ethanol-Associated Genes 
2.1. The D2 Dopamine Receptor 
The mesolimbic dopamine system plays an important role in the rewarding and reinforcing effect of 
drugs on the brain [10,11]. It is thought to play a similar role in the rewarding effect of ethanol, as 
ethanol administration induces the release of dopamine in the nucleus accumbens [12]. 
Of the five dopamine receptor subtypes, the D2 receptor subtype (DRD2) has been extensively 
studied in alcoholism [13-23]. In rats, a decreased DRD2 density is associated with a preference for 
ethanol  [14],  and  transient  overexpression  in  the  nucleus  accumbens  attenuated  ethanol  
preference [15].  In humans, positron emission tomography studies have revealed decreased DRD2 
availability in the striatum of alcoholics [16,17], and support a hypothesis that a high DRD2 level in 
the striatum is a protective factor against alcoholism [18]. Moreover, polymorphisms of the DRD2 
gene are linked with an altered risk of alcoholism [19-23]. 
Alternative splicing generates two DRD2 isoforms, D2S and D2L. These isoforms differ in that 
D2L has a sixth exon, which encodes its third cytoplasmic region [24]. Although the two isoforms are 
co-expressed, D2S is preferentially expressed in dopaminergic neurons in presynaptic regions, such as 
the substantia nigra and the hypothalamus, and D2L predominates in postsynaptic regions, such as the 
striatum and the pituitary gland [25-27]. In recombinant cell lines and mouse brains, D2L has a lower 
affinity for dopamine than D2S [24,28,29]. DRD2 is coupled with Gʱi, an adenylyl cyclase-inhibiting G 
protein, and because Gʱi binding is mediated by the third cytoplasmic loop of DRD2, D2S and D2L 
have different specificities for the subtypes of Gʱi [30-32].  
The D2S and D2L isoforms also differ in their effects on downstream protein phosphorylation. D2S 
has  been  suggested  to  decrease  the  phosphorylation  of  tyrosine  hydroxylase,  and  D2L  has  been 
suggested  to  increase  the  dopamine  D1  receptor  (DRD1)-induced  phosphorylation  of  DARPP-32 
(dopamine- and cAMP-regulated phosphoprotein of 32 kDa) [33]. In addition, D2S and D2L have been 
reported to differ in the levels of their accumulation in the endoplasmic reticulum (ER) [34] and in the 
regulation  of  their  sequestration  by  G  protein-coupled  receptor  kinases  and  β-arrestins  [35]. 
Furthermore, although both D2L and D2S participate in the presynaptic inhibition of γ-aminobutyric 
acid (GABA) release in the striatum, the presynaptic inhibition of glutamate release is preferentially Int. J. Environ. Res. Public Health 2010, 7                 
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modulated  by  D2S  [36].  D2L-deficient  mice  showed  distinct  pharmacological  behavior  from  
DRD2-deficient  mice  and  wild-type  mice,  suggesting  that  the  D2L  splice  variant  has  different 
functions from D2S in vivo [27,29,37,38]. 
Ethanol affects the alternative splicing of DRD2 pre-mRNA [39]. Ethanol administration to rats has 
been  reported  to  increase  the  D2L/D2S  receptor  ratio  in  the  pituitary  gland,  and  this  effect  was 
reproduced in primary cultures of pituitary cells treated with ethanol. We separately confirmed this 
effect of ethanol on DRD2 splicing in the human neuroblastoma cell line SH-SY5Y (unpublished 
data). In pituitary cells, ethanol not only alters DRD2 splicing, but also diminishes the inhibition of 
prolactin secretion by the DRD2-specific analog bromocriptine [39]. These facts suggest that ethanol 
suppresses  dopamine-induced  responses  by  altering  DRD2  splicing.  Allelic  expression  analysis  in 
human postmortem brain tissues and functional magnetic resonance imaging measurements in healthy 
humans  have  shown  that  T  carriers  of  single-nucleotide  polymorphisms  (SNPs)  rs2283265  and 
rs1076560, both of which flank DRD2 exon 6, express relatively fewer D2S receptors and exhibit 
worse  performance  during  working  tasks  [40].  We  have  demonstrated  that  T  carriers  of  SNP 
rs1076560 have a higher alcoholism risk [22]. 
These findings suggest that individuals possessing fewer D2S receptors, such as T carriers, have less 
intense  responses  to  dopamine  (like  ethanol-preferring  rats)  and  therefore  prefer  to  drink  alcohol. 
Furthermore,  this  tendency  is  enhanced  through  a  positive  feedback  loop  in  which  ethanol 
administration decreases the number of D2S receptors.  
2.2. The N-Methyl-D-aspartate (NMDA) Receptor NR1 Subunit 
The  NMDA  (N-methyl-D-aspartate)  receptor,  an  ionotropic  glutamate  receptor  in  the  central 
nervous system, is a pivotal target of ethanol [41]. Ethanol attenuates NMDA receptor function in a 
dose-related fashion in vitro [42,43]. The NMDA receptor is a heteromeric protein composed of at 
least one NR1 subunit and at least one NR2 subunit. Ethanol appears to bind to the NR1 subunit in a 
hydrophobic  pocket  associated  with  the  third  transmembrane  domain  [44].  Ligand  binding  to  the 
NMDA  receptor  is  up-regulated  in  rodents  chronically  treated  with  ethanol  [43,45-48]  and  in 
postmortem cortical tissue from alcoholic patients [49,50]. This up-regulation of the NMDA receptor 
reduces ethanol sensitivity and therefore contributes to ethanol tolerance [51]. 
The NMDA receptor is a cation channel with high Ca
2+ permeability. The NR1 subunit is essential 
for receptor–channel function, and the NR2 subunit modulates the properties of the channel [52]. The 
recently  identified  NMDA  subunit  NR3  decreases  NMDA-induced  current  and  Ca
2+  
permeability [53,54]. 
The NR1 subunit has eight isoforms generated by alternative splicing of exons 5, 21, and 22. The 
NR1-a  variant  lacks  exon  5,  which  encodes  the  N1  splice  cassette  that  lies  in  the  extracellular  
N-terminal domain of the NR1 subunit, and NR1-b includes exon 5. Exons 21 and 22 encode the  
C-terminal splice cassettes C1 and C2, respectively, and are part of the intracellular domain of the NR1 
subunit. NR1 splice variants lacking exon 22 contain a C2’ cassette as an additional cassette at their  
C-terminal  end  (see  Figure  1  in  reference  [55]).  These  splice  variants  vary  considerably  in  their 
properties and are differentially localized in adult and developing animals [56,57]. Int. J. Environ. Res. Public Health 2010, 7                 
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These alternative cassettes modulate the properties of the NMDA receptor. The presence of the N1 
cassette, which forms a surface loop with structural similarities to polyamines, decreases the affinities 
of the receptor for NMDA and glutamate [58]. It potentiates the receptor function by relieving the tonic 
proton inhibition [59] and voltage-independent zinc inhibition [60]. It also accelerates the deactivation 
time  course  of  NMDA  responses  when  NR1  is  co-expressed  with  the  NR2B  (but  not  NR2A)  
subunit [61,62]. The first C1 cassette includes a calmodulin-binding site, and binding of calmodulin to 
NR1 inhibits NMDA channel activity [63-65]. Although the C1 cassette also has protein kinase C 
(PKC) phosphorylation sites, and phosphorylation affects the subcellular distribution of NR1 [66], 
PKC potentiation of the NMDA receptor probably does not occur through direct phosphorylation of the 
receptor but, rather, through phosphorylation of receptor-associated proteins [67,68].  
Interestingly, the NR1 isoforms have differential sensitivities to ethanol-induced inhibition. When 
expressed singly in Xenopus oocytes, the sensitivity of the NR1-1b, NR1-2b, NR1-1a, and NR1-2a 
isoforms to ethanol follows the order NR1-1b > NR1-2b > NR1-1a > NR1-2a [69]. In contrast, when 
all eight NR1 isoforms are co-expressed in various combinations with one of the four NR2 subtypes in 
human embryonic kidney 293 cells,  the  sensitivity depends  on the combination. For example, the  
NR1-3b/NR2C,  NR1-3b/NR2D,  and  NR1-4b/NR2C  pairs  are  most  weakly  inhibited  by  ethanol 
(approximately 15% inhibition), and the NR1-2b/NR2C  pair is  most strongly inhibited by ethanol 
(>50% inhibition) [70]. 
Several  reports  have  described  the  modulation  of  expression  of  specific  NR1  isoforms  by  
ethanol [54,57,71-77]. Some of the reported findings appear to be inconsistent. For example, although 
mRNA ratio of NR1 splice variants containing exon 5 to those lacking exon 5 (+E5/–E5) decreases in 
the cortex of rats  exposed to  ethanol vapor [72] and in  mouse fetal cortical  neurons  treated with  
ethanol  [73],  it  increases  in  the  striatum  of  rats  chronically  treated  with  ethanol  solution  [77].  
Raeder et al. [77] postulated that this inconsistency arises from differences in the dose, duration of 
consumption,  and  route  of  administration  of  alcohol.  In  addition,  the  effects  of  ethanol  on  the 
expression of NR1 isoforms might differ in each brain region. 
Thus, despite this inconsistency, ethanol consumption may increase NR1 isoforms that are weakly 
inhibited by ethanol. Together with up-regulation of the NMDA receptors [37,39-44], this regulation of 
splice  variants  should  contribute  to  the  reduction  of  ethanol  sensitivity  and  the  induction  of  
ethanol tolerance. 
2.3. The GABAA Receptor γ2 Subunit 
The  ionotropic  GABAA  receptor,  a  GABA-gated  chloride  channel  receptor,  is  involved  in  the 
diverse effects of ethanol on the central nervous system [78]. The ionotropic GABAA receptor and the 
metabotropic GABAB receptor mediate the inhibition of neuronal excitability by GABA. The majority 
of fast  synaptic inhibition  is  mediated through the GABAA receptor. Acute ethanol administration 
enhances  GABAA  receptor  activity  at  intoxicating  concentrations,  whereas  chronic  ethanol 
administration  decreases  GABAergic  function  [79-81].  Together with  up-regulation  of the NMDA 
receptor, this down-regulation of the GABAA receptor contributes to ethanol tolerance, dependence, 
and withdrawal hyperexcitability. Ethanol directly binds to a pocket located between transmembrane 
domains of the GABAA receptor, inducing conformational changes [82-84]. Dopaminergic neurons in Int. J. Environ. Res. Public Health 2010, 7                 
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the midbrain are activated not only directly through ethanol exposure, but also indirectly through the 
down-regulation of GABAergic inhibitory transmission to these neurons [85-87]. 
The GABAA receptor is a heteromer of five subunits. Almost all GABAA receptors consist of two ʱ, 
two β, and one γ subunit; the most frequent combinations are ʱ1β2γ2, ʱ2β3γ2, and ʱ3β3γ2, which 
comprise approximately 60, 15, and 10% of GABAA receptor proteins, respectively [88]. Genes for 
these subunits form clusters on several chromosomal regions; 4p13-q11 (ʱ2, ʱ4, β1, γ1), 5q34-q35 (ʱ1, 
ʱ6, β2,  γ2), 15q11-q13 (ʱ5, β3, γ3), and Xq28 (ʱ3, β4, ε1).  Mice with knockouts of these genes 
generally do not exhibit alcohol-preferring behaviors [78]. Moreover, agonists of the GABAA receptor 
enhance  alcohol-drinking  behavior,  and  antagonists  inhibit  it  [89-91].  These  results  illustrate  the 
importance of the GABAA receptor in alcohol consumption. 
The GABAA receptor ʱ2 subunit has four major isoforms differing in their combinations of two 
alternative exons (exon 1A versus exon 1B and exon 9A versus exon 10) and two minor isoforms 
lacking exon 4 or exon 8 [92]. Two haplotypes of the ʱ2 subunit gene (GABRA2) have been reported to 
be  significant  risk  factors  for  AD,  although  this  conclusion  is  inconsistent  with  several  other  
studies [93]. Some non-coding variations in the GABRA2 gene have been found to be associated with 
AD [94]. Because several SNPs are located in exon 8, exon 9, or in the introns flanking these exons, 
one can speculate that these SNPs affect the alternative splicing of these exons. 
The γ2 subunit has two splice variants, one long (γ2L) and one short (γ2S). The γ2L variant differs 
from  the  γ2S  variant  in  that  it  has  an  eight-amino-acid  insert  in  the  intracellular  loop  between 
transmembrane  domains  three  and  four.  Intriguingly,  in  rats,  chronic  intermittent  ethanol 
administration decreases the hippocampal ratio of γ2L/γ2S [95]. The γ2L insert modulates GABAA 
receptor function; it contains a serine residue that is phosphorylated by PKC, reducing the amplitudes 
of GABA-activated currents [96]. In addition, when γ2L is co-expressed with ʱ and β subunits in 
Xenopus oocytes, only the γ2L subunit is sensitive to the reinforcing effect of ethanol [97]. It also 
exhibits accelerated deactivation in human embryonic kidney 293 cells [98]. Knockout mice lacking 
this insert (γ2L-KO) appear to be unaffected in their electrophysiological and behavioral response to 
ethanol [99], contrary to the different effects of the isoforms mentioned above. On the other hand, γ2L 
accumulates  at  inhibitory  postsynaptic  sites  more  effectively  than  γ2S,  and  this  accumulation  is 
facilitated by PKC phosphorylation of the γ2L insert [100]. Meier and Grantyn argue that γ2S functions 
sufficiently in γ2L-KO mice only because it does not have to compete with γ2L for gephyrin binding 
sites and that it actually differs from γ2L in its properties [100]. Moreover, expression of the γ2L and 
ʱ1 subunits increases during development; they are the predominant isoforms in mature GABAergic 
synapses [101]. Thus, a reduced γ2L/γ2S ratio probably interferes with the maturation of inhibitory 
synapses and may indicate a higher risk of alcoholism. 
2.4. N-Type and L-type Voltage-gated Ca
2+ Channels 
Opening of voltage-gated Ca
2+ channels depends on the membrane potential. The resulting influx of 
Ca
2+  into  the  cell  triggers  various  events  including  neurotransmitter  release.  Ca
2+  channels  are 
composed  of  at  least  three  subunits  (ʱ1,  ʱ2δ,  and  β).  The  ʱ1  subunit  is  critical  for  Ca
2+  channel 
functions, and its various subtypes confer functional diversity. Int. J. Environ. Res. Public Health 2010, 7                 
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The N-type Ca
2+ channel is involved in the molecular and behavioral effects of ethanol. Acute 
ethanol exposure inhibits  the activity of the N-type channel in PC12 cells [102], whereas chronic 
ethanol  exposure  increases  the  density  of  N-type  channels  and  therefore  increases  depolarization-
evoked Ca
2+ influx [103]. In addition, mice lacking N-type channels exhibit reduced voluntary ethanol 
consumption and preference [104]. Treatment with the mixed N-type and T-type channel antagonist 
NP078585 has a phenotypic effect similar to that of ethanol [105]. 
The ʱ1 subunit of the N-type channel is ʱ12.2, which has three alternative exons (exon 18a, exon 
24a, and exon 31a). The splice variants of these exons exhibit functionally diverse Ca
2+ signaling in 
neurons. Exon 31a encodes two amino acids in the IVS3-IVS4 linker, altering the rate of channel 
opening  and  the  voltage  dependence  of  channel  activation  [106,107].  Chronic  ethanol  exposure 
decreases expression of the variant lacking exon 31a and increases the N-type current [108], suggesting 
that  ethanol  facilitates  the  functions  of  N-type  Ca
2+  channels  by  altering  the  composition  of  
splice variants. 
The L-type channel is also involved in ethanol consumption. Acute ethanol exposure inhibits the  
L-type channel, whereas chronic ethanol exposure induces a rise in the voltage-gated Ca
2+ current, an 
effect thought to reflect up-regulation of the L-type channel [109,110]. In addition, L-type channel 
antagonists  decrease  ethanol  withdrawal  symptoms  and  ethanol  self-administration  in  
rodents [111,112]. 
The ʱ1C subunit of the L-type channel has two splice variants, ʱ1C-1 and ʱ1C-2. These variants differ 
in that ʱ1C-1 has three additional amino acid residues between domains II and III and 28 additional 
residues in the S3 segment in domain IV. They are differentially expressed in rat brain [113], but little 
is known about their differences in function. Ethanol treatment in PC12 cells has been reported to 
increase the level of ʱ1C protein in a PKCδ activity-dependent manner, whereas it increases the mRNA 
level  of  ʱ1C-1,  but  not  ʱ1C-2,  independent  of  PKCδ  [114].  These  results  indicate  that  ethanol  
up-regulates the L-type channel by increasing expression of the ʱ1C-1 splice variant, in addition to 
PKCδ-dependent and post-transcriptional regulation. 
Ethanol consumption appears to alter the ratios of splice variants, thereby up-regulating N- and  
L-type calcium channels. This up-regulation appears to induce the neuronal hyperexcitability observed 
during ethanol withdrawal. 
2.5. Large-Conductance Calcium- and Voltage- Activated Potassium Channels (BK) 
BK channels are large-conductance calcium- and voltage-activated potassium channels. K
+ currents 
carried by BK channels participate in repolarization and hyperpolarization of action potentials, setting 
neuron firing properties [115]. BK channels consist of  core and  auxiliary subunits. The  core 
subunit forms a ion-selective pore, a voltage-sensing module, and a Ca
2+-sensing module important for 
activation of the channel [116]. 
The activity of BK channels is modified by clinical doses of ethanol. Ethanol exposure potentiates 
BK activity in cell-free membranes and a cultured explant from rat posterior pituitary gland [117,118]. 
And BK channels in pituitary tumor (GH3) cells are also activated by ethanol [119]. This potentiation 
of BK channels in pituitary cells may contribute to the regulation of hormone secretion. Additionally, 
in a subgroup of primary sensory neurons in rat dorsal root ganglia, the BK potentiation by ethanol Int. J. Environ. Res. Public Health 2010, 7                 
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reduces neuronal excitability, and therefore, may underlie analgesic action in the peripheral nervous 
system [120]. Conversely, BK channels in arterial smooth muscle are inhibited by ethanol [121,122]. 
This  ethanol-induced  inhibition  of  BK  channels  may  be  a  mechanism  underlying  contraction  of 
vascular smooth muscle. And protracted ethanol exposure decreases ethanol sensitivity and the number 
of functional BK channels by cellular internalization, resulting in the tolerance to ethanol [118,123]. 
The response and adaptation of BK channels to ethanol is modulated by the phosphorylation state of 
the channel protein [124], membrane lipid environment [125-127], and the composition of  auxiliary 
subunits [123,128]. Moreover, altered expression of splice variants encoding the  core subunit is an 
underlying mechanism for the ethanol tolerance of BK channels [129]. Pietrzykowski and colleagues 
reported that, in the supraoptic nucleus and the striatal neurons, brief ethanol exposure decreased the 
splice  variants  of  BK  channels  that  are  highly  sensitive  to  ethanol.  This  down-regulation  of 
alternatively spliced BK variants is caused by selective degradation of pre-existing mRNA, not by the 
regulation of alternative splicing. Ethanol exposure increases the expression of a miRNA (miR-9) that 
binds to 3’UTR sequence specific to the ethanol-sensitive splice variants, and therefore, enhances the 
degradation of these splice variants. And this molecular tolerance of BK channels to ethanol may 
contribute to the behavioral adaptation to ethanol. 
2.6. Neurexin-3 
In addition to modulating neurotransmitter receptors and ion channels, ethanol has been reported to 
inhibit cell–cell adhesion [130] and neurite outgrowth mediated by the L1 cell adhesion molecule 
(L1CAM) [131]. Ethanol directly binds to L1CAM at a critical domain interface [132] and disrupts its 
signaling cascade [133], suggesting that cell adhesion molecules are targets of ethanol. 
The neuronal proteins known as neurexins function as cell adhesion molecules at presynaptic sites 
with  extracellular  binding  partners,  such  as  neuroligins,  dystroglycan,  and  neurexophilins  [134]. 
Neurexins modulate postsynaptic differentiation and receptor clustering [135] and perform an essential 
role  in  Ca
2+-triggered  neurotransmitter  release  by  modulating  voltage-dependent  Ca
2+  
channels [136-138]. The gene for one of the neurexin family proteins, neurexin-3, is associated with 
nicotine dependence [139,140], opioid dependence [141], and poly-substance abuse [142], and cocaine 
exposure increases neurexin-3 expression in the globus pallidus of mice [143]. Moreover, neurexin-3 is 
expressed in neurons projecting to brain regions involved in addictive behaviors, such as the nucleus 
accumbens and the striatum [144] (http://www.brain-map.org/). 
Neurexin genes have two distinct promoters from which longer forms (ʱ-neurexins) and shorter 
forms (β-neurexins) are transcribed. In addition, ʱ-neurexins have five alternative splice sites (splice 
sites 1–5) and β-neurexins have two (splice sites 4 and 5). In this way, an enormously diverse range of 
neurexin  proteins  are  generated  from  each  neurexin  gene,  and  this  diversity  modulates  synaptic 
functions [145]. For example, alternative splicing at splice site 4 modulates the binding affinity and 
specificity for neuroligins [146]. 
The  splice  site  producing  the  greatest  variety  of  proteins  is  splice  site  5  of  neurexin-3,  which 
includes three exons (exons 22, 23, and 24). Exon 23 is very important because its inclusion confers 
solubility  on  neurexin-3  isoforms,  and  the  transcripts  lacking  this  exon  encode  transmembrane 
isoforms. SNP rs8019381, which is in the intronic sequence adjacent to the donor splice site of exon 23, Int. J. Environ. Res. Public Health 2010, 7                 
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is  strongly  associated  with  alcohol  dependence  and  forms  a  haplotype  block  with  rs760288  and 
rs2293847 [147]. Furthermore, T allele carriers of rs8019381 express fewer soluble isoforms lacking 
exon  23.  Therefore,  this  polymorphism  might  increase  the  risk  of  alcoholism  by  affecting  the 
alternative splicing of exon 23 and modulating the synaptic function of neurexin-3. 
3. Concluding Remarks 
Ethanol consumption can modulate not only the level of total transcripts of multiple genes, but also 
the ratio of their splice variants. Because splice variants have different functions, the altered expression 
of splice variants can ultimately affect behavior such as alcohol dependence. Indeed, as mentioned in 
this  review,  splice  variants  of  DRD2  may  affect  ethanol  preference  by  modulating  dopamine 
sensitivity. And lower ethanol-sensitive splice variants of NMDA receptor, GABAA receptor, and ion 
channels contribute to ethanol tolerance. In addition, splice variants of GABAA receptor, voltage-gated 
Ca
2+  channels,  and  neurexin-3  possibly  contribute  to  withdrawal  symptoms  by  inducing  neuronal 
hyperexcitability. Furthermore, these propensities for ethanol can enhance ethanol consumption in turn. 
We  propose  this  positive  feedback  as  a  mechanism  underlying  the  development  of  alcoholism. 
Moreover, among candidate genes mentioned above, DRD2 and neurexin-3 have polymorphisms that 
are associated with both the risk of alcoholism and the expression ratio of splice variants. Therefore, 
polymorphisms without amino acid alteration in multiple candidate genes probably increase the risk of 
alcoholism by modulating the expression of alternatively spliced variants. 
Many  intriguing  questions  remain  to  be  answered,  such  as  how  ethanol  affects  the  splicing 
machinery. The oxidative stress induced in ethanol metabolism might be a factor; ethanol consumption 
results in the production of reactive oxygen species by the mitochondrial electron transport chain, 
cytochrome P450 2E1, and activated phagocytes [148], and chemical stresses are known to affect the 
splicing of specific pre-mRNAs [149]. 
Another  question  concerns  the  genome-wide  ethanol-associated  changes  in  alternative  splicing. 
Ethanol-associated splice variants have thus far been investigated only for specific genes, not for the 
entire genome. For a genome-wide study, next generation sequencing is a useful screening tool for 
detecting both the altered expression of splice variants and alcoholism-associated polymorphisms. And 
a custom microarray such as the one generated by Johnson and colleagues [150] is also useful for 
studies of alternative splicing in multifactorial disorders including alcoholism. 
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